Ceribell (CBLL) Change in Receivables (2023 - 2026)
Ceribell (CBLL) posted Change in Receivables of $659000.0 for Q1 2026, down 76.62% on a QoQ basis from $2.8 million in Q4 2025, and up 56.53% year-over-year from $421000.0 in Q1 2025.
Ceribell (CBLL) Change in Receivables (2023 - 2026) Analysis & Trends
Ceribell's Change in Receivables history runs 4 years deep, the most recent figure standing at $659000.0 for Q1 2026.
- Quarterly Change in Receivables rose 56.53% year-over-year to $659000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 85.65% YoY) and the FY2025 annual result came in at $4.2 million, up 42.83% from the prior year.
- Change in Receivables was $659000.0 for Q1 2026 at Ceribell, down from $2.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.8 million in Q4 2025 and bottomed at -$78000.0 in Q3 2025.
- A 4-year average of $883600.0 and a median of $832500.0 in 2024 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 248.11% in 2025, while the deepest fall reached 110.26% in 2025.
- Ceribell's Change in Receivables stood at $1.1 million in 2023, then declined by 16.13% to $905000.0 in 2024, then jumped by 211.49% to $2.8 million in 2025, then sank by 76.62% to $659000.0 in 2026.
- Business Quant data shows CBLL's Change in Receivables at $659000.0 in Q1 2026, $2.8 million in Q4 2025, and -$78000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 659,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 659,000.00 |
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | -78,000.00 |
| Sep 30, 2025 | -78,000.00 |
| Jun 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 421,000.00 |
| Mar 31, 2025 | 421,000.00 |
| Dec 31, 2024 | 905,000.00 |
| Dec 31, 2024 | 905,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Sep 30, 2024 | 760,000.00 |
| Jun 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 291,000.00 |
| Mar 31, 2024 | 967,000.00 |
| Mar 31, 2024 | 967,000.00 |
| Dec 31, 2023 | 1.08 Mn |
| Dec 31, 2023 | 1.08 Mn |